Two-pill regimens of misoprostol after mifepristone medical abortion through 63 days' gestational age: a randomized controlled trial of sublingual and oral misoprostol

被引：24
|
作者：
Raghavan, Sheila [1 ]
Comendant, Rodica [2 ]
Digol, Irena [2 ]
Ungureanu, Sergiu [2 ]
Friptu, Valentin [2 ]
Bracken, Hillary [1 ]
Winikoff, Beverly [1 ]
机构：
[1] Gynu Hlth Projects, New York, NY 10010 USA
[2] State Med & Pharm Univ, Municipal Clin Hosp 1, Kishinev 2001, Moldova
来源：
CONTRACEPTION | 2009年 / 79卷 / 02期
关键词：
Medical abortion; Mifepristone; Misoprostol; Sublingual; Oral; EARLY-PREGNANCY TERMINATION; PLACEBO-CONTROLLED TRIAL; VAGINAL MISOPROSTOL; ACCEPTABILITY; COMBINATION; EXPERIENCES; EFFICACY; SAFETY; RU-486; INDIA;
D O I：
10.1016/j.contraception.2008.09.001
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
Background: A 400 mcg dose of sublingual misoprostol has high efficacy and few side effects when used with 200 mg mifepristone for medical abortion through 63 days' gestation. Study Design: Eligible and consenting women (n=480) were randomized to 400 mcg of misoprostol sublingually or orally, 24 h after 200 mg of mifepristone. Abortion status was assessed two weeks later. Results: Complete abortion occurred in 98.7% of the sublingual group and 94.0% of the oral group (p value=.006, RR: 1.05, 95% CI=1.01-1.09). Over 90% of women in both arms expressed high satisfaction with the method. Side effects were similar in both groups, with only fever or chills reported by significantly more women in the sublingual arm. Conclusions: The sublingual route appears Superior to the regimen of 400 mcg misoprostol used orally and may be a good option for mifepristone medical abortion. (C) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码：84 / 90
页数：7
相关论文
共 46 条
  • [21] Randomized trial of mifepristone and buccal or vaginal misoprostol for abortion through 56 days of last menstrual period
    Middleton, T
    Schaff, E
    Fielding, SL
    Scahill, M
    Shannon, C
    Westheimer, E
    Wilkinson, T
    Winikoff, B
    CONTRACEPTION, 2005, 72 (05) : 328 - 332
  • [22] Two prophylactic medication approaches in addition to a pain control regimen for early medical abortion < 63 days' gestation with mifepristone and misoprostol: study protocol for a randomized, controlled trial
    Dragoman, Monica V.
    Grossman, Daniel
    Kapp, Nathalie
    Nguyen My Huong
    Habib, Ndema
    Duong Lan Dung
    Tamang, Anand
    REPRODUCTIVE HEALTH, 2016, 13 : 1 - 10
  • [23] Misoprostol dose and route after mifepristone for early medical abortion: a randomised controlled noninferiority trial
    von Hertzen, H.
    Huong, N. T. M.
    Piaggio, G.
    Bayalag, M.
    Cabezas, E.
    Fang, A. H.
    Gemzell-Danielsson, K.
    Hinh, N. D.
    Mittal, S.
    Ng, E. H. Y.
    Chaturachinda, K.
    Pinter, B.
    Puscasiu, L.
    Savardekar, L.
    Shenoy, S.
    Khomassuridge, A.
    Tuyet, H. T. D.
    Velasco, A.
    Peregoudov, A.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2010, 117 (10) : 1186 - 1196
  • [24] Randomized trial of oral versus vaginal misoprostol 2 days after mifepristone 200 mg for abortion up to 63 days of pregnancy (vol 66, pg 247, 2002)
    Schaff, EA
    Fielding, SL
    Westhoff, C
    CONTRACEPTION, 2002, 66 (06) : 481 - 481
  • [25] A randomised clinical trial comparing the sublingual and buccal routes of administration of misoprostol after mifepristone for medical termination of pregnancy of up to 63 days of gestation
    Chai, J.
    Wong, C. Y. G.
    Ho, P. C.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2012, 119 : 139 - 139
  • [26] Randomized study of sublingual and oral misoprostol following mitepristone 200 mg for abortion up to 63 days' gestation in moldova
    Raghavan, S.
    Comedant, R.
    Winikoff, B.
    CONTRACEPTION, 2007, 76 (02) : 159 - 160
  • [27] Double-blind randomized trial of mifepristone in combination with vaginal gemeprost or misoprostol for induction of abortion up to 63 days gestation
    Bartley, J
    Brown, A
    Elton, R
    Baird, DT
    HUMAN REPRODUCTION, 2001, 16 (10) : 2098 - 2102
  • [28] A prospective randomized comparison of sublingual and oral misoprostol when combined with mifepristone for medical abortion at 12-20 weeks gestation
    Tang, OS
    Chan, CCW
    Kan, ASY
    Ho, PC
    HUMAN REPRODUCTION, 2005, 20 (11) : 3062 - 3066
  • [29] The potential of two non-vaginal routes of misoprostol administration following mifepristone for medical abortion up to 63 days gestation
    Dzuba, I
    Britton, T.
    Creinin, M. D.
    Goldberg, A.
    Hanson, R.
    Lichtenberg, E. S.
    Molaei, M.
    Prine, L.
    Winikoff, B.
    CONTRACEPTION, 2007, 76 (02) : 161 - 162
  • [30] Acceptability and feasibility of the use of 400 μg of sublingual misoprostol after mifepristone for medical abortion up to 63 days since the last menstrual period: Evidence from Uzbekistan
    Raghavan, Sheila
    Tsereteli, Tamar
    Kamilov, Asamidin
    Kurbanbekova, Dilfuza
    Yusupov, Dilmurod
    Kasimova, Feruza
    Jymagylova, Dilbar
    Winikoff, Beverly
    EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE, 2013, 18 (02): : 104 - 111
12345